Sword Health secured $40 million in new capital at a $4 billion valuation this year, while CEO Virgílio Bento officially postponed any initial public offering until at least 2028 to prioritize private growth. The digital health unicorn continues to defy traditional scale-up trajectories, opting for strategic private rounds over the volatility of public markets.
The Strategic Logic Behind Avoiding Wall Street
Virgílio Bento, the visionary leader of Sword Health, expressed deep skepticism regarding the immediate benefits of going public. After evaluating the landscape, Bento concluded that the traditional arguments for an IPO—such as brand recognition and capital access—no longer hold the same weight for high-performing startups. He emphasized that strong private companies can secure massive capital injections without the regulatory burdens of the stock market, citing Databricks’ recent $10 billion raise as a prime example of this trend.
Bento draws inspiration from enduring private giants like Ikea and Lego, proving that global dominance does not require a ticker symbol. Bento noted that after an extensive period of evaluation, he found numerous reasons to avoid the public markets and virtually no compelling reason to join them at this stage of the company’s evolution.
Numerical Symmetry and the $5 Billion Milestone
The company is following a highly disciplined and almost rhythmic funding pattern. Last year, Sword Health raised $30 million at a $3 billion valuation. This year’s $40 million injection at a $4 billion valuation sets the stage for a predictable future. Bento projects another round in 2025, likely totaling $50 million at a $5 billion valuation, a sequence he describes as “numerical symmetry” that reflects the company’s steady upward trajectory.
Addressing the needs of early stakeholders and staff, Sword Health is leveraging secondary markets to provide liquidity. The company plans to launch a tender offer as early as next month, ensuring that employees can realize the value of their shares without the necessity of a public exit. This move reinforces the CEO’s stance that private markets now offer the same financial flexibility once exclusive to public entities.
Backing from Global Venture Powerhouses
This latest funding round brings Sword Health’s total capital raised to $380 million, solidifying its position as a leader in the musculoskeletal (MSK) health space. The cap table remains one of the most prestigious in the industry, featuring a diverse group of investors committed to the company’s long-term vision. Key participants in the recent $40 million round include:
- Khosla Ventures
- Comcast Ventures
- Lince Capital
- Oxy Capital
- Armilar
- Indico Capital
- Shilling
By securing this support, Sword Health maintains the financial runway necessary to continue its technological expansion while remaining insulated from the short-term pressures of quarterly public reporting.
